GlassScriptPrepare for your visit
Alvin H Schmaier
Hematology & Oncology · Cleveland, OH · NPI 1578583134
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$25,394.78
in general payments reported to CMS, 2019-2025 · $603 in 2025
The $603 reported for 2025 was less than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Who reported paying
General payments only, top 6 by amount.
- Merck Sharp & Dohme LLC $7,851.97
- Csl Behring $7,629.52
- Hema Biologics, LLC $2,507.84
- Shire North American Group INC $2,222.44
- Dova Pharmaceuticals $1,357.50
- Genzyme Corporation $910.26
Drugs and devices associated with these payments
Enjaymo Cablivi Ultomiris Fotivda Jakafi Lenvima Scemblix Fabhalta Tivdak Keytruda Imfinzi Ayvakit
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Alvin Schmaier listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/116151/alvin-h-schmaier